FEMTOGENIX LTD has a total of 35 patent applications. It increased the IP activity by 60.0%. Its first patent ever was published in 2015. It filed its patents most often in United Kingdom, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are DAJITI FARMAS JUTIKAL KO LTD, SHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD and AGIOS PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 10 | |
#2 | United States | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Canada | 2 | |
#6 | Australia | 1 | |
#7 | China | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Thurston David Edwin | 22 |
#2 | Jackson Paul Joseph Mark | 22 |
#3 | Rahman Khondaker Mirazur | 21 |
#4 | David Edwin Thurston | 3 |
#5 | Paul Joseph Mark Jackson | 3 |
#6 | Khondaker Mirazur Rahman | 2 |
#7 | Procopiou George | 1 |
#8 | Thurston David | 1 |
#9 | Jackson Paul | 1 |
#10 | Khondake Mirazur Rahman | 1 |
Publication | Filing date | Title |
---|---|---|
GB202100200D0 | Cytotoxic compounds | |
GB202011653D0 | Cytotoxic compounds | |
GB201901197D0 | G-A Crosslinking cytotoxic agents | |
GB201814281D0 | Cytotoxic agents | |
US2018339985A1 | Pdd compounds | |
GB201714115D0 | Cytotoxic agents | |
GB201710054D0 | PBC compounds | |
WO2017194960A1 | Asymmetric conjugate compounds | |
GB201620407D0 | Asymmetric conjugate compounds | |
GB201610710D0 | PBC compounds | |
GB201608408D0 | Asymmetric conjugate compounds |